University of Houston at IDWeek 2026

Oct 21–24, 2026 Washington, DC ~12k attendees Website

University of Houston brings 2 presentations to IDWeek 2026 in Washington. Its program centres on hard treatment decisions in infection care. It looks at how managing discordant Clostridioides difficile test results relates to short-term mortality, and joins University of Utah Health and others on treatment conundrums.

OrganizationIDWeek 2026 Attendance
Poster
Thu Oct 22
12:15pm–1:30pm
Management of discordant Clostridioides difficile test results (GDH+/EIA-) association with 30-day all-cause mortality
Poster Hall B-C · Poster P-1544
N8. Health Care-Associated Infections: C. difficile
Session
Thu Oct 22
1:45pm–3:00pm
Treatment Conundrums - Not Always Black & White
152 AB
Epi & Infection Control · with University of Utah Health, Western Michigan University Homer Stryker M.D. School of Medicine, Minneapolis VA Health Care System +1 more
Global and public healthHIV, sexually transmitted infections and viral hepatitisAntimicrobials, resistance and stewardship

Explore the full IDWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full IDWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from University of Houston

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction